Related Experiment Videos
Development and standardisation of DNA vaccines
1Department of Medical Biotechnology, Paul-Ehrlich-Institut, Langen, Germany.
Developments in Biological Standardization
|January 1, 2000
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Special considerations for the regulation of biological medicinal products in individualised medicine. More than stratified medicine].
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2013
Relevance of an academic GMP Pan-European vector infra-structure (PEVI).
Current gene therapy·2010
[Approval of clinical trials of immunobiological medicinal products at the Paul Ehrlich Institute].
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2005
International challenges and public policy issues.
Developments in biological standardization·2000
Standardisation and licensing of combination vaccines based on DTP.
Developments in biological standardization·2000
The transmissible spongiform encephalopathy agents: concerns and responses of United States regulatory agencies in maintaining the safety of biologics.
Developments in biological standardization·2000
Cytokine and growth factor standardization: the need for research to answer modern issues.
Developments in biological standardization·2000
Alternatives to the use of animals for bacterial toxins and antitoxins.
Developments in biological standardization·2000
Cell substrates: lessons learned and challenges remaining.
Developments in biological standardization·2000
Knowledge and Attitudes Toward Attention-Deficit/Hyperactivity Disorder Among Physicians and Senior Medical Students in Jordan.
Advances in medical education and practice·2026
The 'Other' face of health security: Reimagining epistemic attachments in global health.
PLOS global public health·2026
Community-Identified Barriers and Strategies for Improving HPV Vaccination in South Texas.
Health promotion practice·2026